Analytical methods knowledge base
How to Interpret a Peptide Chromatogram
A practical reading order for axes, detector signal, main and impurity peaks, integration, retention information, blanks and suitability evidence.
Method-aware interpretation
Read the result as a chain of evidence.
Each section connects the analytical question, reporting basis and conclusion boundary.
Orient the trace before judging it
The horizontal axis normally represents time and the vertical axis detector response, but the detector and units must be identified. A trace should be linked to sample name, lot, injection, method, acquisition date and channel. Cropped images can remove the information needed to understand the run.
- Check the full run time and whether the trace begins before the solvent front.
- Confirm the reported channel or wavelength.
- Look for scale changes that make small peaks appear absent or exaggerated.
A peak is a signal assignment, not a conclusion
Peak identity may be supported by a reference standard, relative retention, spectral or mass evidence, but retention time alone is generally not a complete molecular identification. Co-elution can hide components; shoulders or asymmetry can signal limited separation; integration settings influence reported areas.
- Inspect the baseline and integration start/end points.
- Ask how unresolved or excluded peaks are handled.
- Check whether early solvent or system peaks are distinguished from sample-related components.
Read sample, blank and suitability together
A sample chromatogram is stronger when the blank excludes relevant carryover or interference, the standard establishes the expected response and system suitability demonstrates adequate performance. The chromatogram should be interpreted within the complete analytical sequence rather than as a standalone marketing image.
- Confirm carryover control when a high-concentration injection precedes the sample.
- Review repeatability or replicate information when the method requires it.
- Preserve raw-data references and processing method versions for traceability.
Decision table
What the field means—and what it does not prove
Use this table to prevent a valid analytical result from being expanded beyond its intended purpose.
↔ Swipe horizontally to read every column
| Record or question | What it can support | What it does not prove |
|---|---|---|
| Peak area | Integrated detector response for the selected region | Mass fraction without response and method justification |
| Retention time | Elution time under the stated conditions | Unique molecular identity by itself |
| Resolution / suitability | Whether defined separation performance was achieved | Absence of every possible impurity |
Interpretation limits
Stop where the method stops.
- A screenshot cannot substitute for controlled raw data when formal release decisions are required.
- Chromatographic response factors may differ among components.
- Only the defined method scope supports the reported conclusion.
Primary and technical sources
Records used for this guide
Sources are linked directly so the wording, date and scope can be checked independently.
- 01Source record
USP General Chapter <621> Chromatography
United States Pharmacopeia. USP–NF General Chapter <621>.
- 02Source record
Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration. Guidance for Industry, July 2015.
- 03Source record
ICH Q2(R2): Validation of Analytical Procedures
International Council for Harmonisation. Step 4, adopted November 2023; error-corrected 2025.
Knowledge center